Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) · SIC 2820
Kraig Biocraft Laboratories, Inc.
KBLB
Latest revenue
$0
as of 2021-06-30
Latest net income
$-2.8M
as of 2021-06-30
Net margin
—
as of 2021-06-30
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $142.9M
- Enterprise value
- $142.9M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $0.16
- 52-wk low
- $0.07
- Beta
- —
- Shares out
- 1.10B
5-year trend
What this company does
ITEM 1. DESCRIPTION OF BUSINESS. Overview Kraig Biocraft Laboratories, Inc., a Wyoming corporation, is a corporation organized to develop high strength fibers using recombinant DNA technology for commercial applications including technical textiles. We use genetically engineered silkworms that produce spider silk proteins to create our recombinant spider silk. Applications include performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics and more. We believe that we are the world’s leading company in the research, development, and production of commercially scalable and cost-effective recombinant spider silk fiber. Our primary proprietary…
AI summary unavailable — showing raw filing excerpt
Generated from KBLB's filing dated 2026-03-30
Key risks
ITEM 1A. RISK FACTORS. As the Company is a smaller reporting company, this item is not applicable; however, we encourage you to review the risk factors included in our other publicly filed reports.
AI summary unavailable — showing raw filing excerpt
Generated from KBLB's filing dated 2026-03-30
Profitability
Return on equity
45.3%
8.6%Return on assets
-141.2%
37.5%Leverage
Debt / equity
-1.32×
11.5%Long-term debt / equity
-0.02×
Debt / assets
411.8%
35.8%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | — | — | $-942.7K | -57.1% | — |
Q4 2025 2025-12-31 | — | — | $-787.6K | +7.5% | — |
Q3 2025 2025-09-30 | — | — | $-1.5M | -248.5% | — |
Q2 2025 2025-06-30 | — | — | $-726.1K | +54.8% | — |
Q1 2025 2025-03-31 | — | — | $-600.0K | -18.1% | — |
Q4 2024 2024-12-31 | — | — | $-851.7K | — | — |
Q3 2024 2024-09-30 | — | — | $-433.2K | +21.1% | — |
Q2 2024 2024-06-30 | — | — | $-1.6M | -172.7% | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) · SIC 2820
Your notes
Keep private notes on KBLB — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$0
Net activity
+$0
Distinct insiders
0
Open-market trades over the last 365 days.
Recent transactions
| Date | Insider | Type | Shares | Price | Value |
|---|
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns KBLB
Institutional value
$5.5K
Total shares held
50.0K
Distinct holders
1
+0 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | Hurley Capital, LLC | 50.0K | $5.5K | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once KBLB's latest filing finishes processing.